COSMOS Pharmaceutical Corporation
3349.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥57,038,000 | ¥52,301,000 | ¥45,928,000 | ¥37,362,000 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥12,240,000 | ¥12,199,000 | ¥10,221,000 | ¥8,577,000 |
| Inventory | ¥92,323,000 | ¥86,173,000 | ¥77,479,000 | ¥66,363,000 |
| Other Curr. Assets | ¥1,164,000 | ¥1,092,000 | ¥1,028,000 | ¥980,000 |
| Total Curr. Assets | ¥165,622,000 | ¥154,333,000 | ¥137,085,000 | ¥115,471,000 |
| Property Plant & Equip (Net) | ¥331,125,000 | ¥295,798,000 | ¥274,655,000 | ¥239,035,000 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥446,000 | ¥497,000 | ¥547,000 | ¥433,000 |
| Long-Term Investments | ¥4,464,000 | ¥4,386,000 | ¥4,310,000 | ¥4,179,000 |
| Tax Assets | ¥2,913,000 | ¥2,893,000 | ¥2,268,000 | ¥1,966,000 |
| Other NC Assets | ¥20,185,000 | ¥18,636,000 | ¥2,095,000 | ¥1,966,000 |
| Total NC Assets | ¥359,133,000 | ¥322,210,000 | ¥283,875,000 | ¥247,579,000 |
| Other Assets | ¥4,000 | ¥3,000 | ¥7,000 | ¥2,000 |
| Total Assets | ¥524,755,000 | ¥476,546,000 | ¥420,967,000 | ¥363,052,000 |
| Liabilities | – | – | – | – |
| Payables | ¥177,125,000 | ¥179,549,000 | ¥161,852,000 | ¥139,224,000 |
| Short-Term Debt | ¥5,682,000 | ¥4,581,000 | ¥2,741,000 | ¥1,387,000 |
| Tax Payable | ¥0 | ¥5,572,000 | ¥6,275,000 | ¥4,995,000 |
| Deferred Revenue | ¥380,000 | ¥522,000 | ¥519,000 | ¥350,000 |
| Other Curr. Liab. | ¥27,177,000 | ¥13,017,000 | ¥12,894,000 | ¥8,426,000 |
| Total Curr. Liab. | ¥220,680,000 | ¥213,229,000 | ¥192,053,000 | ¥162,063,000 |
| LT Debt | ¥37,202,000 | ¥23,385,000 | ¥10,018,000 | ¥3,000,000 |
| Deferred Rev, NC | ¥0 | ¥4,166,000 | -¥442,000 | -¥451,000 |
| Deferred Tax Liab, NC | ¥416,000 | ¥432,000 | ¥442,000 | ¥451,000 |
| Other NC Liab. | ¥4,591,000 | ¥4,325,000 | ¥4,126,000 | ¥4,125,000 |
| Total NC Liab. | ¥46,610,000 | ¥31,876,000 | ¥17,842,000 | ¥10,482,000 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥7,073,000 | ¥6,097,000 | ¥5,442,000 | ¥5,026,000 |
| Total Liabilities | ¥267,290,000 | ¥245,105,000 | ¥209,895,000 | ¥172,545,000 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥4,178,000 | ¥4,178,000 | ¥4,178,000 | ¥4,178,000 |
| Retained Earnings | ¥248,309,000 | ¥222,284,000 | ¥202,485,000 | ¥181,954,000 |
| AOCI | ¥100,000 | ¥102,000 | ¥40,000 | ¥5,000 |
| Other Equity | ¥2,000 | ¥2,000 | ¥0 | ¥0 |
| Total Equity | ¥257,463,000 | ¥231,442,000 | ¥211,071,000 | ¥190,506,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥524,755,000 | ¥476,544,000 | ¥420,966,000 | ¥363,051,000 |
| Net Debt | -¥14,154,000 | -¥24,335,000 | -¥33,169,000 | -¥32,975,000 |